TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biofokus
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
21,755
|
20,206
|
20,187 |
| Financial expenses |
3
|
0
|
1 |
| Earnings before taxes |
1,906
|
1,012
|
1,919 |
| Total assets |
28,009
|
26,292
|
26,059 |
| Current assets |
27,807
|
26,088
|
26,023 |
| Current liabilities |
8,178
|
6,597
|
7,765 |
| Equity capital |
19,831
|
19,695
|
18,293 |
| - share capital |
49
|
53
|
51 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
70.8%
|
74.9%
|
70.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
8.8%
|
5.0%
|
9.5% |
| Return on assets (ROA) |
6.8%
|
3.8%
|
7.4% |
| Current ratio |
340.0%
|
395.5%
|
335.1% |
| Return on equity (ROE) |
9.6%
|
5.1%
|
10.5% |
| Change turnover |
2,888
|
-607
|
-819 |
| Change turnover % |
15%
|
-3%
|
-4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.